72 related articles for article (PubMed ID: 26410020)
21. Pathologically determined tumor volume vs pathologic T stage in the prediction of outcome after surgical treatment of oropharyngeal squamous cell carcinoma.
Nixon IJ; Palmer FL; Lakin P; Kattan MM; Lee NY; Ganly I
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1151-5. PubMed ID: 24092047
[TBL] [Abstract][Full Text] [Related]
22. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
[TBL] [Abstract][Full Text] [Related]
23. The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma.
Ljøkjel B; Haave H; Lybak S; Aarstad HH; Karlsdottir A; Vintermyr OK; Aarstad HJ
Acta Otolaryngol; 2014 Sep; 134(9):964-73. PubMed ID: 24963968
[TBL] [Abstract][Full Text] [Related]
24. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
[TBL] [Abstract][Full Text] [Related]
25. Management of the "violated neck" in the era of chemoradiation.
Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
[TBL] [Abstract][Full Text] [Related]
26. Recurrent oropharyngeal cancer after organ preserving treatment: pattern of failure and survival.
de Ridder M; Gouw ZAR; Sonke JJ; Navran A; Jasperse B; Heukelom J; Tesselaar MET; Klop WMC; van den Brekel MWM; Al-Mamgani A
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1691-1700. PubMed ID: 27942891
[TBL] [Abstract][Full Text] [Related]
27. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
[TBL] [Abstract][Full Text] [Related]
28. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
29. Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.
Kwan JYY; Su J; Huang SH; Ghoraie LS; Xu W; Chan B; Yip KW; Giuliani M; Bayley A; Kim J; Hope AJ; Ringash J; Cho J; McNiven A; Hansen A; Goldstein D; de Almeida JR; Aerts HJ; Waldron JN; Haibe-Kains B; O'Sullivan B; Bratman SV; Liu FF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1107-1116. PubMed ID: 29506884
[TBL] [Abstract][Full Text] [Related]
30. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
[TBL] [Abstract][Full Text] [Related]
31. Interactions between clinical factors, p16, and cyclin-D1 expression and survival outcomes in oropharyngeal and hypopharyngeal squamous cell carcinoma.
Ang SH; Haaland B; Acharyya S; Thu MM; Krisna SS; Hwang SG; Tan PH; Ng QS; Tan DS; Tai WM; Tan EH; Lim WT; Ang MK
Head Neck; 2015 Nov; 37(11):1650-9. PubMed ID: 24953865
[TBL] [Abstract][Full Text] [Related]
32. Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.
Rietbergen MM; Witte BI; Velazquez ER; Snijders PJ; Bloemena E; Speel EJ; Brakenhoff RH; Kremer B; Lambin P; Leemans CR
Br J Cancer; 2015 May; 112(11):1733-6. PubMed ID: 25950384
[TBL] [Abstract][Full Text] [Related]
33. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Maxwell JH; Grandis JR; Ferris RL
Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of Human Papillomavirus-Associated Head and Neck Cancers in a Veteran Population.
Shay SG; Chang E; Lewis MS; Wang MB
JAMA Otolaryngol Head Neck Surg; 2015 Sep; 141(9):790-6. PubMed ID: 26270931
[TBL] [Abstract][Full Text] [Related]
35. Early Response Assessment on Mid-treatment Computed Tomography Predicts for Locoregional Recurrence in Oropharyngeal Cancer Patients Treated With Definitive Radiation Therapy.
Kabarriti R; Brodin NP; Lundgren G; Ohri N; Tomé WA; Kalnicki S; Garg MK
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1036-1045. PubMed ID: 29779936
[TBL] [Abstract][Full Text] [Related]
36. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.
Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P
Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290
[TBL] [Abstract][Full Text] [Related]
37. Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.
Huang YH; Yeh CH; Cheng NM; Lin CY; Wang HM; Ko SF; Toh CH; Yen TC; Liao CT; Ng SH
PLoS One; 2017; 12(7):e0180779. PubMed ID: 28686646
[TBL] [Abstract][Full Text] [Related]
38. Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
Dave E; Su W; Gupta V; Miles B; Demicco E; Soriano T; Bakst RL
Anticancer Res; 2017 Apr; 37(4):1847-1851. PubMed ID: 28373450
[TBL] [Abstract][Full Text] [Related]
39. Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.
Gillison ML; Zhang Q; Jordan R; Xiao W; Westra WH; Trotti A; Spencer S; Harris J; Chung CH; Ang KK
J Clin Oncol; 2012 Jun; 30(17):2102-11. PubMed ID: 22565003
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
Bigelow EO; Harris J; Fakhry C; Gillison ML; Nguyen-Tân PF; Rosenthal DI; Frank SJ; Nair SG; Bahig H; Ridge JA; Caudell J; Donaldson C; Clifford BT; Shenouda G; Birrer MJ; Chen Y; Le QT
Head Neck; 2022 Jan; 44(1):158-167. PubMed ID: 34729846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
